a month ago
RVMD
AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Top 7%
#363 out of 5296 analysts
Average Return
+48.28%
Win Rate
63%22 out of 35
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Century Therapeutics IncIPSC | +336.04% | $0.56 | $2.42 | 2025-03-21 - 2026-03-20 | Strong Buy |
Revolution Medicines IncRVMD | +321.10% | $36.54 | $153.87 | 2025-08-19 - 2026-06-12 | Strong Buy |
Tango Therapeutics IncTNGX | +195.40% | $6.96 | $20.56 | 2025-08-19 - 2026-05-15 | Strong Buy |
Erasca IncERAS | +171.76% | $5.17 | $14.05 | 2026-01-07 - 2026-06-12 | Strong Buy |
Genelux CorpGNLX | +147.25% | $3.09 | $7.64 | 2024-10-29 - 2025-10-28 | Strong Buy |
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
3 months ago
ERAS
4 months ago
RVMD
5 months ago
TNGX
5 months ago
ERAS
5 months ago
CGON
7 months ago
DAWN
8 months ago
NUVL
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Leonabio IncLONA | 1 | Strong Buy | $20.00 | +139.52% | Initiates Coverage On | 19 days ago |
Tango Therapeutics IncTNGX | 3 | Hold | $24.00 | -22.43% | Downgrades | a month ago |
Janux Therapeutics IncJANX | 3 | Strong Buy | $26.00 | +91.74% | Maintains | a month ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $172.00 | +11.78% | Maintains | a month ago |
Summit Therapeutics IncSMMT | 2 | Hold | $16.00 | +14.20% | Maintains | a month ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $12.00 | +80.45% | Initiates Coverage On | 3 months ago |
Erasca IncERAS | 3 | Strong Buy | $18.00 | +28.11% | Maintains | 3 months ago |
Arcellx IncACLX | 3 | Hold | $115.00 | -0.06% | Downgrades | 4 months ago |
Cg Oncology IncCGON | 2 | Strong Buy | $70.00 | +17.53% | Maintains | 5 months ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +357.14% | Maintains | 5 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $24.00 | +515.38% | Initiates Coverage On | 5 months ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $22.00 | +166.02% | Initiates Coverage On | 5 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $26.00 | +20.76% | Maintains | 7 months ago |
Nuvalent IncNUVL | 4 | Strong Buy | $128.00 | +3.85% | Maintains | 8 months ago |
Urogen Pharma LtdURGN | 3 | Strong Buy | $36.00 | +21.13% | Initiates Coverage On | 10 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $36.00 | +65.98% | Initiates Coverage On | 10 months ago |
Century Therapeutics IncIPSC | 2 | Strong Buy | $5.00 | N/A | Maintains | a year ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.